Arvind Sommi

Jun 30, 2023 | diatribe.org | Arvind Sommi

From continuous ketone monitoring to automatic insulin that only works when you need it, a panel of diabetes experts shares what they think diabetes therapy and care will look like in the next 5-10 years. The treatment of diabetes has changed dramatically since the first successful administration of insulin more than a century ago.

Jun 30, 2023 | diatribe.org | Arvind Sommi

Packed with fiber, protein, and essential nutrients, beans can aid in managing blood sugar levels, promoting heart health, and providing energy. Here’s which beans are best for people with diabetes and which varieties should be eaten in limited quantities. Beans, with their numerous health benefits and versatility, are an excellent addition to a well-balanced diet for people with diabetes.

Jun 29, 2023 | diatribe.org | Arvind Sommi

The FDA has approved Lantidra (donislecel), a revolutionary treatment for people living with type 1 diabetes. Lantidra works by restoring the body’s beta cells, potentially eliminating the need for external insulin. Lantidra (donislecel), a cell therapy that helps to restore functional pancreatic islet cells in patients unable to produce insulin, has become the first cell therapy to ever be approved by the FDA for people with type 1 diabetes.

Jun 27, 2023 | diatribe.org | Arvind Sommi

Jun 27, 2023 | l8r.it | Anna Brooks |Arvind Sommi

Clinical trial participants taking retatrutide for obesity experienced an average of 24% in body weight reduction over 48 weeks. Lead scientists shared their findings at the ADA’s 83rd Scientific Sessions in San Diego. A new medication by Eli Lilly called retatrutide – a GIP/GLP-1/glucagon receptor triagonist – had significant weight loss effects for people living with obesity. In one phase 2 trial, the experimental drug helped study participants lose up 24% of their body in less than a year.